Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial

Autor: Moses, Agnes, Kanyama, Cecilia, Mukwekwerere, Pamela, Gudza, Ivy, Chauwa, Felluna, Ulaya, Godwin, Kutto, Irene, Cheruiyot, Priscilla, Okello, Clement, Nakaganda, Annet, Koskei, Geoffrey, Keter, Winnie, Netto, Juliana, Baião, Tamiris, Govender, Iveshni, O'Connell-Maritz, Jessica, Cain, Kevin, Okanda, John, Cornelissen, Lynne, Van Schalkwyk, Marije, Sikhosana, Rejoice, Ngcobo, Minenhle, Lee, Jeannette Y., Harrison, Taylor, Wachsman, William, Shin, Katherine, Evans, Scott, Rothenberg, Jennifer, Hosey, Lara, McCarthy, Sean, Martinez-Maza, Otoniel, Rinaldo, Charles, Dittmer, Dirk, Fletcher, Courtney, Rudek, Michelle, Asmelash, Aida, Hughes, Valery, Schouten, Jeffrey, Shugarts, David, Kujinga, Tapiwanashe, Zadzilka, Amanda, Kerui, Fredrick, Robertson, Debora, Rooney, James, Sewal, Krishna, Gottshall, Brian, Krown, Susan E ^*, Moser, Carlee B, MacPhail, Patrick, Matining, Roy M, Godfrey, Catherine, Caruso, Stephanie R, Hosseinipour, Mina C, Samaneka, Wadzanai, Nyirenda, Mulinda, Busakhala, Naftali W, Okuku, Fred M, Kosgei, Josphat, Hoagland, Brenda, Mwelase, Noluthando, Oliver, Vincent O, Burger, Henriette, Mngqibisa, Rosie, Nokta, Mostafa, Campbell, Thomas B, Borok, Margaret Z

Publikováno v: In The Lancet 11-17 April 2020 395(10231):1195-1207

Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.

Autor: Busakhala, Naftali W., Waako, Paul J., Strother, Matthew Robert, Keter, Alfred Kipyegon, Kigen, Gabriel Kimutai, Asirwa, Fredrick Chite, Loehrer, Patrick J.

Publikováno v: Journal of Global Oncology; 2017, Vol. 4, p1-9, 9p

Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.

Autor: Busakhala NW; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Waako PJ; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Strother MR; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Keter AK; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Kigen GK; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Asirwa FC; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Loehrer PJ; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN.

Publikováno v: Journal of global oncology [J Glob Oncol] 2018 Sep; Vol. 4, pp. 1-9.